Log in

NASDAQ:PAHCPhibro Animal Health Stock Price, Forecast & News

$26.20
-0.70 (-2.60 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$25.57
Now: $26.20
$26.74
50-Day Range
$22.31
MA: $24.14
$28.29
52-Week Range
$16.87
Now: $26.20
$33.97
Volume137,834 shs
Average Volume172,076 shs
Market Capitalization$1.06 billion
P/E Ratio29.11
Dividend Yield1.83%
Beta0.47
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Israel, Latin America, Canada, Europe, Africa, and the Asia/Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. The company is headquartered in Teaneck, New Jersey. Phibro Animal Health Corporation is a subsidiary of BFI Co., LLC.
Read More
Phibro Animal Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.2Dividend Strength: 3.3Insider Behavior: 2.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.83 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAHC
CUSIPN/A
Phone201-329-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$828 million
Cash Flow$2.24 per share
Book Value$4.83 per share

Profitability

Net Income$54.71 million

Miscellaneous

Employees1,600
Market Cap$1.06 billion
Next Earnings Date8/25/2020 (Estimated)
OptionableOptionable

Receive PAHC News and Ratings via Email

Sign-up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.

Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions

How has Phibro Animal Health's stock been impacted by COVID-19 (Coronavirus)?

Phibro Animal Health's stock was trading at $24.58 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PAHC shares have increased by 6.6% and is now trading at $26.20. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Phibro Animal Health?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Phibro Animal Health.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is scheduled to release its next quarterly earnings announcement on Tuesday, August 25th 2020. View our earnings forecast for Phibro Animal Health.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Corp (NASDAQ:PAHC) issued its quarterly earnings results on Thursday, May, 7th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.34 by $0.04. The business earned $210.70 million during the quarter. Phibro Animal Health had a return on equity of 24.23% and a net margin of 4.48%. View Phibro Animal Health's earnings history.

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health announced a quarterly dividend on Monday, May 4th. Stockholders of record on Wednesday, June 3rd will be paid a dividend of $0.12 per share on Wednesday, June 24th. This represents a $0.48 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date is Tuesday, June 2nd. View Phibro Animal Health's dividend history.

What price target have analysts set for PAHC?

5 brokerages have issued 1 year target prices for Phibro Animal Health's shares. Their forecasts range from $18.00 to $30.00. On average, they expect Phibro Animal Health's stock price to reach $24.80 in the next twelve months. This suggests that the stock has a possible downside of 5.3%. View analysts' price targets for Phibro Animal Health.

Has Phibro Animal Health been receiving favorable news coverage?

Headlines about PAHC stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Phibro Animal Health earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutPhibro Animal Health.

Are investors shorting Phibro Animal Health?

Phibro Animal Health saw a increase in short interest in April. As of April 30th, there was short interest totaling 771,200 shares, an increase of 7.4% from the April 15th total of 718,100 shares. Based on an average daily volume of 192,900 shares, the days-to-cover ratio is currently 4.0 days. Approximately 3.8% of the shares of the stock are short sold. View Phibro Animal Health's Current Options Chain.

Who are some of Phibro Animal Health's key competitors?

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Intercept Pharmaceuticals (ICPT), Sonoma Pharmaceuticals (SNOA), Zoetis (ZTS), Zynerba Pharmaceuticals (ZYNE), Banco Bradesco (BBD), Booking (BKNG) and Epirus Biopharmaceuticals (EPRSQ).

Who are Phibro Animal Health's key executives?

Phibro Animal Health's management team includes the following people:
  • Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 72)
  • Mr. Larry L. Miller, Chief Operating Officer (Age 55)
  • Mr. Dean J. Warras, Pres of Animal Health & Nutrition - North America (Age 50)
  • Mr. Richard G. Johnson, Chief Financial Officer (Age 70)
  • Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 61)

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (8.19%), Principal Financial Group Inc. (4.86%), State Street Corp (1.80%), Janus Henderson Group PLC (1.68%), Fiduciary Management Inc. WI (1.57%) and Nuveen Asset Management LLC (1.28%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, E Thomas Corcoran and Jack Bendheim. View institutional ownership trends for Phibro Animal Health.

Which major investors are selling Phibro Animal Health stock?

PAHC stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Janus Henderson Group PLC, BlackRock Inc., Wells Fargo & Company MN, Eagle Asset Management Inc., Mackay Shields LLC, Squarepoint Ops LLC, and Fiduciary Management Inc. WI. View insider buying and selling activity for Phibro Animal Health.

Which major investors are buying Phibro Animal Health stock?

PAHC stock was bought by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Copper Rock Capital Partners LLC, Raymond James & Associates, Nuveen Asset Management LLC, Parametric Portfolio Associates LLC, Ziegler Capital Management LLC, State Street Corp, and 361 Capital LLC. View insider buying and selling activity for Phibro Animal Health.

How do I buy shares of Phibro Animal Health?

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $26.20.

How big of a company is Phibro Animal Health?

Phibro Animal Health has a market capitalization of $1.06 billion and generates $828 million in revenue each year. The company earns $54.71 million in net income (profit) each year or $1.53 on an earnings per share basis. Phibro Animal Health employs 1,600 workers across the globe.

What is Phibro Animal Health's official website?

The official website for Phibro Animal Health is www.pahc.com.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]

This page was last updated on 5/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.